Literature DB >> 6268182

Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes.

H I Thieden, J J Holst, J Dich, A Moody, F Sundby.   

Abstract

We studied the effect of the highly purified gut peptide glicentin on the glucose production and cyclic AMP accumulation of isolated rat hepatocytes. Glicentin at 2.10(-7) mol/l had the same effect on glucose production as maximally effective concentrations of glucagon, but did not stimulate cyclic AMP to the same extent; furthermore, glicentin apparently had only 1/100 of the potency of glucagon on glucose production. During incubation with hepatocytes glicentin was degraded to low molecular weight fragments one of which were chromatographically very similar to fragments of glucagon. It is suggested that glicentin exerts its glucagon-like effects on hepatocytes only after degradation to glucagon-like fragments. The results also demonstrate that the coupling between cyclic AMP accumulation and glucose production depends on the nature of the stimulatory peptide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268182     DOI: 10.1016/0304-4165(81)90222-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro.

Authors:  S Myojo; T Tsujikawa; M Sasaki; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

Review 2.  Insights on glicentin, a promising peptide of the proglucagon family.

Authors:  Juliette Raffort; Fabien Lareyre; Damien Massalou; Patrick Fénichel; Patricia Panaïa-Ferrari; Giulia Chinetti
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

Review 3.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 4.  The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.

Authors:  J Michael Conlon
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-11       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.